Becton Dickinson stock (US0718131099): insider filings and ownership changes draw attention

Becton Dickinson shares on the New York Stock Exchange were in focus on Saturday as fresh institutional ownership disclosures underscored changing positions in the United States-based medical technology group. According to a filing summary reported by MarketBeat on 05/30/2026, National Pension Service increased its holdings in Becton, Dickinson and Company in the latest reported quarter, while several smaller institutions also adjusted their stakes in the NYSE-listed stock, which trades under the ticker BDX.

The stock most recently changed hands around USD 172.95 on the NYSE on 05/29/2026, down 1.82% for that session according to Zacks price data, leaving Becton Dickinson some distance below earlier 2026 levels. In Germany, the shares are also available via off-exchange platforms such as Tradegate, typically quoted in euros for retail investors. Against this backdrop, the latest fund-position updates provide an additional data point for investors ahead of the company’s next scheduled earnings release on 08/06/2026, which Zacks lists as the upcoming results date.

The most recent quarterly figures, reported ahead of that August date, showed earnings per share of USD 3.35, marginally above the Zacks Consensus Estimate of USD 3.28 per share for that period, according to Zacks as of 05/30/2026. While the beat was modest, it indicates that Becton Dickinson continues to execute broadly in line with market expectations in its core medical technology and supplies businesses. Combined with ongoing portfolio changes, such as the previously announced transaction involving BD Biosciences & Diagnostic Solutions and Waters Corporation, the group remains active on both operational and strategic fronts.

From a United States perspective, Becton Dickinson sits within the large-cap healthcare segment and is a long-established component of the domestic medical technology landscape. The company’s shares are closely followed by US-based analysts and institutions, while regulatory and product developments, such as device recalls recorded in Food and Drug Administration databases, continue to be monitored by market participants. For German-speaking investors, access to the stock via venues like Tradegate provides an additional route to participate in the US healthcare theme while trading in euros.

As of: 05/30/2026

By the editorial team - specialized in equity coverage.

Becton Dickinson: core business model

Becton Dickinson focuses on developing and supplying a broad range of medical devices, diagnostic tools and interventional products that support hospitals, laboratories and healthcare providers worldwide, with sales driven largely by recurring demand for consumables and systems in medication management, diagnostics and minimally invasive procedures.

Insider activity and ownership structure

The latest ownership disclosures highlight that institutional investors remain actively engaged with Becton Dickinson. MarketBeat reported on 05/30/2026 that National Pension Service grew its position in shares of Becton, Dickinson and Company in the most recently reported quarter, alongside changes in stakes by other institutions such as WPG Advisers LLC, which raised its holding by 64.2% in the fourth quarter to 156 shares. While the absolute size of some of these positions is modest, the data underlines that a broad base of institutions continues to adjust exposure to the United States medical technology name.

These filings sit alongside the company’s long-term profile as a widely held large-cap stock in the US healthcare sector, where mutual funds, pension schemes and other professional investors typically represent a significant share of the shareholder base. Formal insider transactions by company executives and directors are reported through US Securities and Exchange Commission filings, while institutional ownership summaries compiled by outlets such as MarketBeat and other data providers give investors an additional lens on how professional money managers are positioning around Becton Dickinson.

Conclusion

The latest institutional ownership updates, including the increased stake by National Pension Service reported at the end of May, bring Becton Dickinson back into focus for investors monitoring positioning in US healthcare names. With the shares trading around USD 172.95 on the NYSE as of 05/29/2026 and the next earnings date scheduled for 08/06/2026, the market will be watching whether upcoming results confirm the group’s ability to sustain earnings in line with or ahead of consensus expectations. For both US and German-speaking investors, the combination of evolving ownership patterns, portfolio moves and the company’s role in global medical technology will remain key factors to track over the coming months.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.